Thyrotoxicosis causing arterial and venous thrombosis.
We present an interesting case of a patient with thyrotoxicosis who developed both arterial and venous thrombosis. Although there have been reports of thrombosis in such patients, there has been no case reporting arterial and venous thrombosis in the same patient. We describe the case and discuss the medical literature. We feel that any patient with unexplained hypercoagulability should be thoroughly evaluated for thyroid dysfunction.
Lodha
Ankur
A
Department of Internal Medicine, Maimonides Medical Center, Brooklyn, New York, USA. ankurlodha@gmail.com
Haran
Mehandi
M
Frankel
Robert
R
Shani
Jacob
J
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008713:Methimazole / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D013971:Thyrotoxicosis / Q000097:blood / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000097:blood / Q000188:drug therapy / Q000209:etiology*
D000925:Anticoagulants; D013956:Antithyroid Agents; D008713:Methimazole; D011433:Propranolol